Vext Science, Inc. Q2 2026 Earnings Recap

Shares rose 4.2% following Q2 as margin expansion and successful execution on the Arizona cultivation exit and Ohio expansion outweighed flat revenue and earlier pricing missteps.

Key Takeaways

• Revenue was $12.1 million, roughly flat sequentially but down 10% year-over-year, reflecting a planned pullback in Arizona wholesale.
• Gross margin improved substantially to 55% from 36% a year ago, driven by higher retail mix and better cultivation yields surpassing 100 grams per plant.
• Adjusted EBITDA increased for the second consecutive quarter, underscoring ongoing profitability progress despite top-line pressures.
• Ohio retail continues to drive growth including a new dispensary opened in June; however, a pricing error on flower in Ohio temporarily cost volume but has since been corrected.
• Arizona cultivation was wound down as planned amid declining state market sales and unattractive wholesale prices; focus shifted to third-party sourcing and operating two dispensaries, with customer traffic rebounding notably.